Three new drug launches in 2014 won't save Teva's sales if generics attack Copaxone later this week. But they certainly can't hurt.
written on 21.05.2014
Three new drug launches in 2014 won't save Teva's sales if generics attack Copaxone later this week. But they certainly can't hurt.
See our Cookie Privacy Policy Here